09/03/2026
Atrophic scars can be challenging to treat, and selecting the right approach often depends on the unique characteristics of each patient and scar type. In this review published in the Journal of Clinical and Aesthetic Dermatology, Dr. Scott Stratman and Dr. Helen He examine the role of trichloroacetic acid (TCA) CROSS, a targeted technique used in the management of atrophic scars.
The authors explore how TCA CROSS fits into the broader treatment landscape, including its use as a standalone procedure and alongside other modalities such as lasers, microneedling, subcision, platelet-rich plasma, and dermal fillers. The review also highlights considerations for diverse patient populations and the importance of individualized treatment planning.
The findings suggest that TCA CROSS remains a valuable option for scar management, particularly when treatment strategies are tailored to a patient's specific needs and goals.
📖 Read the study: https://bit.ly/4zcyq7A
The Mount Sinai Hospital Icahn School of Medicine at Mount Sinai